Monitoring blood flow to the spinal cord with a skin sensor during major surgery
Tests a skin sensor on back muscles in adults having major surgery.
Key facts
- Who runs it
- Monaldi Hospital
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- NIRS MONITORING OF SPINAL CORD ISCHEMIA IN AORTIC SURGERY
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 23 Aug 2025
- Expected to end
- 30 Mar 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Near-Infrared Spectroscopy (NIRS)
- Cerebrospinal fluid drainage via lumbar catheter (L3-L4) to maintain cerebrospinal fluid pressure below target levels and optimize spinal cord perfusion pressure during aortic surgery.
- Record updated
- 21 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having planned surgery on the aorta in the chest or chest and belly. During surgery, a light sensor on the back checks oxygen in the back muscles.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Planned (not emergency) thoracic or thoracoabdominal aortic repair: open, endovascular (TEVAR/FEVAR) or hybrid surgery.
Main reasons for not taking part
- Emergency surgery
- Pregnancy
- Paralysis of the legs (paraplegia) or severe nerve problems before surgery
- Skin problems that stop the NIRS sensors from being placed correctly
- Not willing or not able to give informed consent
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adult patients aged 18 years or older Patients scheduled for elective thoracic or thoracoabdominal aortic repair, including open, endovascular (TEVAR/FEVAR), or hybrid procedures Patients undergoing intraoperative paraspinal near-infrared spectroscopy (NIRS) monitoring Written informed consent obtained before enrollment
Who cannot take part
- Age under 18 years Emergency surgical procedures Pregnancy Pre-existing paraplegia or severe neurological impairment Skin lesions or conditions preventing correct placement of NIRS sensors Refusal or inability to provide informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective observational study aims to evaluate the feasibility and clinical utility of near-infrared spectroscopy (NIRS) monitoring applied to paraspinal muscles as a surrogate marker of spinal cord perfusion in patients undergoing major noncardiac surgery.
Read full original descriptionShow less
Spinal cord ischemia represents a rare but devastating complication, often difficult to detect in real time. NIRS provides a non-invasive, continuous monitoring of regional tissue oxygen saturation (rSO₂), potentially reflecting microcirculatory changes in paraspinal tissues and indirectly spinal cord perfusion.
The study will enroll adult patients undergoing major surgery requiring advanced hemodynamic monitoring. NIRS sensors will be placed over paraspinal regions, and rSO₂ values will be continuously recorded throughout the perioperative period. Hemodynamic parameters, including arterial pressure, cardiac output, and other relevant clinical variables, will be simultaneously collected.
The primary objective is to assess changes in paraspinal rSO₂ during perioperative management and their relationship with systemic hemodynamic variables. Secondary objectives include the evaluation of the association between rSO₂ variations and postoperative neurological outcomes, as well as the feasibility and reliability of this monitoring technique in routine clinical practice.
This study may provide preliminary evidence supporting the use of NIRS as a bedside, non-invasive tool for early detection of impaired spinal cord perfusion and for guiding hemodynamic optimization strategies.
The 2 groups in the trial
- High-risk patients (NIRS + CSF drainage)
Patients at high risk of spinal cord ischemia undergoing aortic surgery, managed with paraspinal near-infrared spectroscopy (NIRS) monitoring combined with cerebrospinal fluid (CSF) drainage according to the study protocol.
Treatment: Near-Infrared Spectroscopy (NIRS) and Cerebrospinal fluid drainage via lumbar catheter (L3-L4) to maintain cerebrospinal fluid pressure below target levels and optimize spinal cord perfusion pressure during aortic surgery.
- Low-risk patients (NIRS alone)
Patients at lower risk of spinal cord ischemia undergoing aortic surgery, managed with paraspinal near-infrared spectroscopy (NIRS) monitoring without cerebrospinal fluid drainage according to the study protocol.
Treatment: Near-Infrared Spectroscopy (NIRS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MONITORING AND PREVENTION OF SPINAL CORD iSCHEMIA IN AORTIC SURGERY USING PARASPINAL NEAR-INFRARED SPECTROSCOPY (NIRS)
- Plain-language title
- Monitoring blood flow to the spinal cord with a skin sensor during major surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 21 April 2026